Annual CFF:
-$80.95M-$535.05M(-117.83%)Summary
- As of today, AMPH annual cash from financing is -$80.95 million, with the most recent change of -$535.05 million (-117.83%) on December 31, 2024.
- During the last 3 years, AMPH annual cash from financing has fallen by -$43.94 million (-118.69%).
- AMPH annual cash from financing is now -117.83% below its all-time high of $454.09 million, reached on December 31, 2023.
Performance
AMPH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$30.20M-$15.70M(-108.25%)Summary
- As of today, AMPH quarterly cash from financing is -$30.20 million, with the most recent change of -$15.70 million (-108.25%) on June 30, 2025.
- Over the past year, AMPH quarterly cash from financing has dropped by -$19.49 million (-181.84%).
- AMPH quarterly cash from financing is now -107.05% below its all-time high of $428.11 million, reached on June 30, 2023.
Performance
AMPH Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$101.36M-$19.49M(-23.80%)Summary
- As of today, AMPH TTM cash from financing is -$101.36 million, with the most recent change of -$19.49 million (-23.80%) on June 30, 2025.
- Over the past year, AMPH TTM cash from financing has dropped by -$116.60 million (-765.33%).
- AMPH TTM cash from financing is now -120.90% below its all-time high of $485.02 million, reached on September 30, 2023.
Performance
AMPH TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMPH Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -117.8% | -181.8% | -765.3% |
| 3Y3 Years | -118.7% | -3237.2% | -372.7% |
| 5Y5 Years | -2039.9% | -342.5% | -717.4% |
AMPH Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -117.8% | at low | -107.0% | +35.9% | -120.9% | at low |
| 5Y | 5-Year | -117.8% | at low | -107.0% | +35.9% | -120.9% | at low |
| All-Time | All-Time | -117.8% | at low | -107.0% | +35.9% | -120.9% | at low |
AMPH Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$30.20M(-108.2%) | -$101.36M(-23.8%) |
| Mar 2025 | - | -$14.50M(+57.1%) | -$81.88M(-1.1%) |
| Dec 2024 | -$80.95M(-117.8%) | -$33.84M(-48.3%) | -$80.95M(+14.1%) |
| Sep 2024 | - | -$22.82M(-112.9%) | -$94.19M(-718.3%) |
| Jun 2024 | - | -$10.72M(+21.1%) | $15.23M(-96.6%) |
| Mar 2024 | - | -$13.58M(+71.2%) | $454.06M(-0.0%) |
| Dec 2023 | $454.09M(+1817.5%) | -$47.08M(-154.4%) | $454.09M(-6.4%) |
| Sep 2023 | - | $86.61M(-79.8%) | $485.02M(+26.0%) |
| Jun 2023 | - | $428.11M(+3260.0%) | $384.79M(+970.0%) |
| Mar 2023 | - | -$13.55M(+16.2%) | -$44.23M(-69.9%) |
| Dec 2022 | -$26.44M(+28.6%) | -$16.16M(-18.7%) | -$26.03M(-40.2%) |
| Sep 2022 | - | -$13.62M(-1404.5%) | -$18.57M(+13.4%) |
| Jun 2022 | - | -$905.00K(-119.5%) | -$21.45M(+16.7%) |
| Mar 2022 | - | $4.65M(+153.4%) | -$25.73M(+30.5%) |
| Dec 2021 | -$37.02M(-1548.2%) | -$8.70M(+47.3%) | -$37.02M(-29.7%) |
| Sep 2021 | - | -$16.49M(-217.7%) | -$28.55M(-89.3%) |
| Jun 2021 | - | -$5.19M(+21.8%) | -$15.08M(-688.3%) |
| Mar 2021 | - | -$6.64M(-2824.7%) | $2.56M(+214.2%) |
| Dec 2020 | -$2.25M(+40.6%) | -$227.00K(+92.5%) | -$2.25M(+81.9%) |
| Sep 2020 | - | -$3.03M(-124.3%) | -$12.40M(+6.5%) |
| Jun 2020 | - | $12.46M(+208.8%) | -$13.26M(+49.9%) |
| Mar 2020 | - | -$11.45M(-10.3%) | -$26.46M(-599.5%) |
| Dec 2019 | -$3.78M | -$10.38M(-167.0%) | -$3.78M(-116.1%) |
| Sep 2019 | - | -$3.89M(-424.0%) | $23.52M(-48.0%) |
| Jun 2019 | - | -$742.00K(-106.6%) | $45.21M(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $11.23M(-33.6%) | $47.06M(+88.2%) |
| Dec 2018 | $25.01M(+424.0%) | $16.92M(-5.0%) | $25.01M(+243.3%) |
| Sep 2018 | - | $17.80M(+1504.0%) | $7.28M(+145.4%) |
| Jun 2018 | - | $1.11M(+110.3%) | -$16.03M(-134.8%) |
| Mar 2018 | - | -$10.83M(-1250.1%) | -$6.83M(+11.5%) |
| Dec 2017 | -$7.72M(-208.1%) | -$802.00K(+85.5%) | -$7.72M(+5.6%) |
| Sep 2017 | - | -$5.51M(-153.4%) | -$8.18M(-175.7%) |
| Jun 2017 | - | $10.31M(+188.0%) | $10.81M(+340.2%) |
| Mar 2017 | - | -$11.72M(-829.3%) | $2.46M(-65.6%) |
| Dec 2016 | $7.14M(+219.2%) | -$1.26M(-109.4%) | $7.14M(+152.3%) |
| Sep 2016 | - | $13.47M(+586.6%) | $2.83M(+119.7%) |
| Jun 2016 | - | $1.96M(+127.9%) | -$14.36M(-55.4%) |
| Mar 2016 | - | -$7.03M(-26.2%) | -$9.24M(-513.1%) |
| Dec 2015 | $2.24M(-93.0%) | -$5.57M(-49.7%) | $2.24M(+400.3%) |
| Sep 2015 | - | -$3.72M(-152.5%) | -$745.00K(-149.5%) |
| Jun 2015 | - | $7.08M(+59.4%) | $1.50M(-94.5%) |
| Mar 2015 | - | $4.45M(+152.0%) | $27.38M(-14.7%) |
| Dec 2014 | $32.12M(+442.8%) | -$8.55M(-481.0%) | $32.12M(-13.1%) |
| Sep 2014 | - | -$1.47M(-104.5%) | $36.97M(-3.8%) |
| Jun 2014 | - | $32.96M(+259.1%) | $38.44M(+601.5%) |
| Mar 2014 | - | $9.18M(+348.1%) | $5.48M(-6.2%) |
| Dec 2013 | -$9.37M(-140.3%) | -$3.70M(-138.8%) | $5.84M(-38.8%) |
| Mar 2013 | - | $9.54M | $9.54M |
| Dec 2012 | $23.24M(+371.0%) | - | - |
| Dec 2011 | -$8.58M | - | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual cash from financing year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual cash from financing?
The current annual cash from financing of AMPH is -$80.95M
What is the all-time high annual cash from financing for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual cash from financing is $454.09M
What is Amphastar Pharmaceuticals, Inc. annual cash from financing year-on-year change?
Over the past year, AMPH annual cash from financing has changed by -$535.05M (-117.83%)
What is Amphastar Pharmaceuticals, Inc. quarterly cash from financing?
The current quarterly cash from financing of AMPH is -$30.20M
What is the all-time high quarterly cash from financing for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly cash from financing is $428.11M
What is Amphastar Pharmaceuticals, Inc. quarterly cash from financing year-on-year change?
Over the past year, AMPH quarterly cash from financing has changed by -$19.49M (-181.84%)
What is Amphastar Pharmaceuticals, Inc. TTM cash from financing?
The current TTM cash from financing of AMPH is -$101.36M
What is the all-time high TTM cash from financing for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high TTM cash from financing is $485.02M
What is Amphastar Pharmaceuticals, Inc. TTM cash from financing year-on-year change?
Over the past year, AMPH TTM cash from financing has changed by -$116.60M (-765.33%)